New Concepts in Diabetes and Its Treatment - part 7 pdf

... lipoproteins in non-insulin-dependent diabetes mellitus. Diabet Med 19 97; 14(suppl 3): 67 74 .De Man FH, Cabezas MC, Van Barlingen HH, Erkelens DW, de Bruin TW: Triglyceride-rich lipoproteins in non-insulin-dependent ... therapy and progression to clinical albumi-nuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. BMJ 1995;311: 973 – 977 .Mogensen CE: Combined high BP and glucose in type ... Lipopro-teins and coronary heart disease in non-insulin-dependent diabetes mellitus. J Diabetes Complica-tions 19 97; 11:1 37 141.Lopes-Virella MF, Virella G: Modiﬁed lipoproteins, cytokines and macrovascular...

New Concepts in Diabetes and Its Treatment - part 5 pdf

... simultaneous determinations every4–6 h of glycemia, insulinemia and C-peptide during fasting periods of 24,48 and 72 h. In insulinoma, glycemia falls while C-peptide and insulinemiaremain near-unmodiﬁed. ... receptorsmetabolism in childrenSepsisIntake of leucine in leucine-sensitiveInsulin or insulin-releasing drugschildren(sulfonylureas, pentamidine, quinine)Newborn hypoglycemia (ﬁrst hours of ... susceptible to leucine and in about 70 % of patients with insulinoma.(12) Search for antibodies to insulin (if present in persons not receivinginsulin therapy can indicate a surreptitious insulin use)...

New Concepts in Diabetes and Its Treatment - part 9 pdf

... (eds): New Concepts in Diabetes and Its Treatment. Basel, Karger, 2000, pp 218–228 Erectile Dysfunction in Diabetes and Its Treatment M. Tagliabue, G.M. MolinattiDipartimento di Medicina Interna, ... per year, in which case insulin treatment must be initiated to maintain satisfactory gly-caemic control. In a substudy in the UKPDS, the eﬀect of metformin versusconventional treatment and sulphonylureas ... or insulin in obese patients wasexamined. Patients randomized to metformin had lower risks for all-causemortality, strokes and any diabetes- related endpoint than patients on conven-tional treatment, ...

New Concepts in Diabetes and Its Treatment - part 1 ppt

... (lean and/ or trained sub-jects) and elevated (?15 U/ml) in insulin-resistant subjects. It should bepointed out that an apparent normal insulin level in insulin-resistant diabeticsubjects indicates ... changed in type 2patients, suggesting preserved -cell sensitivity in these patients.Insulin Secretion in Type 2 Diabetes Both impaired insulin action (insulin resistance) and reduced insulin secre-tion ... (eds): New Concepts in Diabetes and Its Treatment. Basel, Karger, 2000, pp 20– 37 Insulin Secretion and Its Pharmacological StimulationF. Belﬁore, S. IannelloInstitute of Internal Medicine,...

New Concepts in Diabetes and Its Treatment - part 2 docx

... MAP-K>mitogen-activated protein kinase; PC-1>an ecto-proteinkinase probably interfering with insulin receptor tyrosine kinase; PI3-K>phosphatidyl-inositol-3 kinase; PIP2>phosphatidylinositol-4,5-P; PKA>protein ... threonine (the serine/threonine-spe-ciﬁc protein kinases). The receptor -subunit can be phosphorylated on serine,threonine and tyrosine residues and possesses intrinsic protein-tyrosine kinaseactivity. ... reduce fast-ing hyperglycemia and insulinemia by improving insulin sensitivity in skeletal53Insulin Resistance and Its Relevance to Treatment and in nephropathic diabetic patients.A newly developed...

New Concepts in Diabetes and Its Treatment - part 3 docx

... (a) the rapid-acting, (b) the intermediate-acting and (c) the long-acting insulin. (a) The rapid-acting insulin preparations includethe regular insulin as well as the semilente insulin which is ... to insulin and adjusting the pH. (c) The long-acting insulin prepara-tions include the ultralente insulin, obtained by modifying, during the prepara-tion, the pH of a mixture of zinc and insulin ... suspension ofinsulin and zinc in acetate buﬀer (with formation of zinc-insulin crystals).(b) The intermediate-acting insulins comprise the lente insulin, which is a30 :70 % mixture of semilente and ultralente...

New Concepts in Diabetes and Its Treatment - part 4 ppsx

... Regular and intermediate-acting insulin before breakfast, regular insu-lin before lunch and supper, and intermediate-acting insulin at bedtime (4daily insulin doses).(d) Regular insulin before ... insulins)Pattern of insulin treatment (episodic therapy and CSII may increase insulin immunogenicity)Genetic factors (HLA-A2-B44 and HLA-B44-DR7 predispose to immune complications ofinsulin ... injections,regular and intermediate-acting insulin before breakfast, regular insulin beforesupper and intermediate-acting insulin at bedtime. This 3 times daily insulindose regimen is useful in diabetic...

New Concepts in Diabetes and Its Treatment - part 6 pot

... diabeticretinopathyrequiringphoto-coagulation treatment and intraretinal microvascular abnormalities not requiring treatment New vessels requiring photocoagulation Intraretinal microvascular abnormalities not treatment ... (sometimes153Nephropathy and Hypertension in Diabetic PatientsChapter XIBelﬁore F, Mogensen CE (eds): New Concepts in Diabetes and Its Treatment. Basel, Karger, 2000, pp 152– 173 Nephropathy and Hypertension in Diabetic ... the blood-retina barrier and therefore remains inside the bloodstream. However, in exu-dative diabetic maculopathy the blood-retina barrier is broken down and areaswhere ﬂuorescein leaks out...

Mass Transfer in Multiphase Systems and its Applications Part 6 pdf

... T0= 70 °C and different inlet humidity φ0= 10% (GrT= - 1’180’8 87 and GrM= - 24’359), 30% (GrT= - 1’189 78 2 and GrM= - 226’095) and 70 % (GrT= - 1’208’840 and GrM= - 670 78 9) (Kassim ... for T0= 70 °C and different inlet humidity φ0= 10% (GrT= - 1’180’8 87; GrM= - 24’359), 30% (GrT= - 1’189 78 2; GrM= - 226’095) and 70 % (GrT= - 1’208’840; GrM= - 670 78 9) (Kassim ... different inlet humidity φ0= 10% (GrT= - 1’180’8 87; GrM= - 24’359), 30% (GrT= - 1’189 78 2; GrM= - 226’095) and 70 % (GrT= - 1’208’840; GrM= - 670 78 9) (Kassim et al. 2010a) Axial evolution...

Xem thêm